🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

While amylase & lipase elevation often seen in trials of targeted agents, actual clinical pancreatitis is uncommon. In this retrospective report Clinical Lung Cancer from Drs. Meyer May-Lucie Mihaela Aldea and team, incidence of clinical pancreatitis was .08%! clinical-lung-cancer.com/article/S1525-…

Excited about the IASLC #WCLC2024! If you need a quick refresh on the current treatment of advanced lung cancer, our review is there for you! thelancet.com/journals/lance…

Live from #WCLC2024 in San Diego. Thrilled to see that my amazing boss, Claudia Henschke, is going to receive a well-deserved award! IASLC #lungcancerscreening

This year’s IASLC #WCLC2024 is gonna be about coffee and taking care of a tiny human while following breakthrough in the #lungcancer field. So yes, kind of a big deal!

Yes our baby is the most famous participant #wclc24 IASLC Meyer May-Lucie

Today, I had the great pleasure of speaking at the 1st Conference on Integrating Early Detection of Heart and Lung Disease Through Low-Dose CT. We discussed recurrence and emphasized the importance of lung screening. Long live lung screening! nasser altorki Karen Kelly

How to handle lipase elevation with targeted treatment ? 🔍 we found that pancreatic enzyme elevation is common, but rarely linked to clinical pancreatitis. sciencedirect.com/science/articl…

Glad to see summary from NYLCF’s meeting in March 2024 published. Looking forward to follow up in March 2025!

From New York 🗽 to the world 🌎: Calls to action to improve lung cancer care in Annals of Oncology. Full article here: 🔗 bit.ly/4ga8LlC

#RSNA24 First time in Chicago! 🔥 Getting ready for my presentation on the feasibility of performing NGS on biopsies from small lung tumors. Join me on Monday, December 2, at 9 AM!

#RSNA24 NGS on early stage lung cancer ? 💥 -77 patients -77 biopsies (FNA, CNB, EBUS-TBNA) -DNA Sequencing feasibility -97.4% 🔥 -DNA sequencing deemed high-quality-90.9% 🔥 -RNA Sequencing feasibility- 66.2 %⚠️ Icahn School of Medicine at Mount Sinai

Thank you #RSNA24 City of Chicago I had great encounters, delivered a wonderful presentation, and enjoyed a beautiful run Radiology reigns supreme

Echo screening of TB patients facilitates early detection of CV involvement. Routine echo at baseline in all newly diagnosed TB patients may allow for timely medical management and prevent complications such as constriction and heart failure. JACC Journals sciencedirect.com/science/articl…

🫁 Recurrences after surgery for stage 0 or 1A NSCLC are rare, but half of recurrences involve the suture line, according to a recent study by Louis Gros of Icahn School of Medicine at Mount Sinai, Mount Sinai Health System and colleagues. ➡️ Learn more: buff.ly/oFzX9Q3 #lcsm #LungCancer #NSCLC

Oops! I did it again 🚨 New publication alert! 🚨 Our latest study investigates suture-line recurrence in stage 1A NSCLC, linking it to sublobar resections, smaller margins, and better survival for isolated suture-line recurrence. Icahn School of Medicine at Mount Sinai Mount Sinai Health System

Back to the best city in the world for the New York Lung Cancer Foundation Summit – a great chance to reunite with my inspiring mentors Solange, Claudia and David. I love science, but I love people more Solange Peters Icahn School of Medicine at Mount Sinai

Our Swiss 🇨🇭 friends at work in NY...Louis Gros Meyer May-Lucie

Strategic Call to Action: New York Lung Cancer Foundation 🗽 Inspiring presentations remind us that global health demands equity Let’s bring innovation where it’s needed most Relentlessly focus on the solution NYLCF.org Fred R. Hirsch Solange Peters Harpreet Singh, MD

The answer to your question is Paris. #ELCC2025 Louis Gros Priscilla Cascetta Jordi Remon Solange Peters

We need to work more on better implementation of lung cancer screening. Very good long-term results!